References
- Bastien JP, Roy J, Roy DC (2012). Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. Semin Oncol, 39, 674-82. https://doi.org/10.1053/j.seminoncol.2012.09.004
- Dong WM, Cao XS, Wang B, et al (2014). Allogeneic hemopietic stem cell transplants for the treatment of B cell acute lymphocytic leukemia. Asian Pac J Cancer Prev, 15, 6127-30. https://doi.org/10.7314/APJCP.2014.15.15.6127
- Gu Z, Cai B, Yuan L, et al (2014). Successful treatment of polymorphic post-transplant lymphoproliferative disorder after allo-HSCT with reduction of immunosuppression. Int J Clin Exp Med, 7, 1904-9.
- Holtick U, Frenzel LP, Shimabukuro-Vornhagen A, et al (2014). CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation. Ann Hematol, 94, 129-37.
- Lehrnbecher T, Schmidt S, Tramsen L, et al (2013). Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients. Front Oncol, 3, 17.
- Liu F, Wu T, Wang JB, et al (2013). Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis, 15, 243-50. https://doi.org/10.1111/tid.12068
- Mensen A, Jöhrens K, Anagnostopoulos I, et al (2014). Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT. Blood, 124, 963-72. https://doi.org/10.1182/blood-2013-11-539031
- Mohty B, Mohty M (2011). Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update. Blood Cancer J, 1, 16. https://doi.org/10.1038/bcj.2011.14
- Omer AK, Ziakas PD, Anagnostou T, et al (2013). Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. Biol Blood Marrow Transplant, 19, 1190-6. https://doi.org/10.1016/j.bbmt.2013.05.018
- Perales MA, Goldberg JD, Yuan J, et al (2012). Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood, 120, 4882-91. https://doi.org/10.1182/blood-2012-06-437236
- Perlingeiro Beltrame M, Malvezzi M, Bonfim C, et al (2014). Immune reconstitution in patients with Fanconi anemia after allogeneic bone marrow transplantation. Cytotherapy, 16, 976-89. https://doi.org/10.1016/j.jcyt.2014.02.015
- Qin LL, Wang QR, Wang Q, et al (2013).T-SPOT.TB for detection of tuberculosis infection among hematological malignancy patients and hematopoietic stem cell transplant recipients. Asian Pac J Cancer Prev, 14, 7415-9. https://doi.org/10.7314/APJCP.2013.14.12.7415
- Toubert A1, Glauzy S, Douay C, et al (2012). Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again. Tissue Antigens, 79, 83-9. https://doi.org/10.1111/j.1399-0039.2011.01820.x
- Tacke D, Buchheidt D, Karthaus M, et al (2014). Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the infectious diseases working party of the german society for haematology and oncology. Ann Hematol, 93, 1449-56. https://doi.org/10.1007/s00277-014-2108-y
- Wils EJ, van der Holt B, Broers AE, et al (2011). Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients. Haematologica, 96, 1846-54. https://doi.org/10.3324/haematol.2011.047696
- Yetisyigit T, Babacan N, Urun Y, et al (2014).Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors. Asian Pac J Cancer Prev, 15, 831-5. https://doi.org/10.7314/APJCP.2014.15.2.831